MadeMed vs REMEVi
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Anyone who expects to titrate and wants the eventual cost visible before starting.
- semaglutide
- $179/mosee conditions
- tirzepatide
- $249/mosee conditions
Before enrolling
No state list is published for the injections — only the oral tirzepatide page names its states (40), so injection availability is not known until the consultation
Desk Score
Someone who wants one price that never climbs with the dose — or a Spanish-speaking patient who wants the intake, portal and care team in their own language.
- semaglutide
- $219/mo
- tirzepatide
- $319/mo
Before enrolling
The flat rate is a higher entry price than teaser-led competitors
Our review of REMEVi gives it 86/100 (B), while our review of MadeMed gives it 82/100 (B−). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
82/100
B−
86/100
B
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | MadeMed | REMEVi |
|---|---|---|
| Semaglutide | $179/mosee conditionsFull plan terms$179/mo (billed every 30 days; $483 every 90 days or $1,718 every 360 days; flat at every dose; plus a $20 consultation fee, $30 if a video visit is needed; compounded) | $219/moFull plan terms$219/mo month-to-month; $189/mo on a 12-week plan; $179/mo on a 24-week plan; same price at every dose; oral tablet $349/mo month-to-month or $309/mo on a 12-week plan |
| Tirzepatide | $249/mosee conditionsFull plan terms$249/mo (billed every 30 days; $672 every 90 days or $2,390 every 360 days; flat at every dose; sublingual tablets at the same three prices; plus a $20 consultation fee, $30 if a video visit is needed; compounded) | $319/moFull plan terms$319/mo month-to-month; $249/mo on a 12-week plan; $229/mo on a 24-week plan; same price at every dose; compounded injectable |
| Coverage | Not confirmed for MadeMed. | All 50 states and DC |
| Brand-name | Not confirmed here | Not confirmed here |
| Oral option | Oral option listed | Oral option listed |
| Best for | Anyone who expects to titrate and wants the eventual cost visible before starting. | Someone who wants one price that never climbs with the dose — or a Spanish-speaking patient who wants the intake, portal and care team in their own language. |
| Desk Score | 82/100B− | 86/100B |
The verdict
Desk pick — REMEViREMEVi has the higher Desk Score, but MadeMed may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
Anyone who expects to titrate and wants the eventual cost visible before starting.
Someone who wants one price that never climbs with the dose — or a Spanish-speaking patient who wants the intake, portal and care team in their own language.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs MadeMed
- CoreAge Rx vs REMEVi
- Fitish vs MadeMed
- Curex vs REMEVi
- MadeMed vs No BS RX
- BetterMe Rx vs REMEVi
Or see the full comparison hub and the complete ranking.